Please use this identifier to cite or link to this item:
https://scholarhub.balamand.edu.lb/handle/uob/5222
Title: | AVP-786 as a promising treatment option for Alzheimer's Disease including agitation | Authors: | Khoury, Rita Marx, Charlotte Mirgati, Sidney Velury, Divya Chakkamparambil, Binu Grossberg, George T |
Affiliations: | Faculty of Medicine | Keywords: | Agitation Alzheimer’s Disease avp-786 Deuteration Dextromethorphan Efficacy Pharmacology Quinidine Safety Tolerability |
Issue Date: | 2021 | Publisher: | Taylor & Francis Online | Part of: | Expert Opinion on Pharmacotherapy | Volume: | 22 | Issue: | 7 | Start page: | 783 | End page: | 795 | Abstract: | To date, there is no FDA-approved treatment for agitation in Alzheimer's disease (AD). Medications currently used off-label have modest clinical efficacy and serious side effects. |
URI: | https://scholarhub.balamand.edu.lb/handle/uob/5222 | ISSN: | 14656566 | DOI: | 10.1080/14656566.2021.1882995 | Ezproxy URL: | Link to full text | Type: | Journal Article |
Appears in Collections: | Faculty of Medicine |
Show full item record
SCOPUSTM
Citations
24
checked on Dec 21, 2024
Record view(s)
69
checked on Dec 26, 2024
Google ScholarTM
Check
Altmetric
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.